Peritoneal Metastatic Carcinoma
Conditions
Interventions
Experimental Group :1. Experimental Group: Fu Zheng Yi Qi Formula + Conventional Western Preoperative Therapy Formula Composition: Astragalus (, Astragalus membranaceus) 30g, Codonopsis (, Codonopsis
Blank Group:2. Control Group: Fuzheng Yiqi Formula Placebo (identical administration method, dosage, and treatment duration to the Experimental Group) + Conventional Western Preoperative Therapy
Sponsors
Beijing Shi Jitan Hospital of Capital Medical University
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1) Patients with pathologically (histologically and/or cytologically) confirmed peritoneal cancer; 2) Age 20-75 years; 3) Meeting the indications for CRS and scheduled to undergo CRS; 4) Expected survival time >6 months; 5) Provision of signed informed consent to participate in this study
Exclusion criteria
Exclusion criteria: Exclusion Criteria: Patients with severe concomitant diseases of the heart, liver, kidneys, immune system, or hematopoietic system; Patients unable to cooperate with oral administration of traditional Chinese medicine; Patients with diagnosed depression, anxiety disorders, psychosis, or cognitive impairment; Patients with severe complications, including gastrointestinal or abdominal hemorrhage, digestive tract fistula, abdominal infection, or mechanical intestinal obstruction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)EORTC QLQ-C30;2) Five Zang-Organs Function Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| The observed indicators include: 1) TCM syndrome score; 2) gastrointestinal recovery indicators (time to first flatus/defecation, time to bowel sound recovery); and 3) nutritional and immunological parameters (serum albumin, prealbumin, hemoglobin, and lymphocyte subsets) ; | — |
Countries
China
Contacts
Public ContactJiang Min
Beijing Shijitan Hospital, Capital Medical University?
Outcome results
None listed